Drug Products: Biologics, Biosimilars and Interchangeables
Drug Regulation
Dosage Regimen: Individualization
Drug Control Governance: Regulatory Bodies and Their Impact
Prescription, Nonprescription and Orphan Drugs
Pharmaceutical Poisoning: Potential Scenarios
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 17, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
Aaron S Kesselheim1, Jerry Avorn, Jeremy A Greene
1Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, USA.
No abstract available in PubMed .